coenzymeQ10 for Autosomal recessive spinocerebellar ataxia type II

coenzymeQ10 for Autosomal recessive spinocerebellar ataxia type II - coenzymeQ10 for Autosomal recessive spinocerebellar ataxia type II

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031788

Enrollment

Registered

2018-04-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autosomal recessive spinocerebellar ataxia type II

Interventions

high dose of coenzyme Q10

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient with diagnosed as ARCA II defined of abnormality in ADCK3 gene

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
physical examination, SARA, MRI, SPECT	—

Countries

Japan

Contacts

Public ContactShotaro Haji

Tokushima university Department of Neurology

shotaro.haji@tokushima-u.ac.jp088-633-7207

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026